However, in U87 glioblastoma cells, 6HLN mainly exhibited cancer-stimulatory effects by increasing cell viability, enhancing migratory properties supported by vimentin overexpression, and upregulating the expression of the IL1β proinflammatory protein. The gene discussed is PROS1; the disease is glioblastoma.